Key Insights

Highlights

Success Rate

67% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 77/100

Termination Rate

30.0%

3 terminated out of 10 trials

Success Rate

66.7%

-19.8% vs benchmark

Late-Stage Pipeline

20%

2 trials in Phase 3/4

Results Transparency

33%

2 of 6 completed with results

Key Signals

2 with results67% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (2)
P 1 (1)
P 2 (4)
P 3 (2)

Trial Status

Completed6
Terminated3
Recruiting1

Trial Success Rate

66.7%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (10)

Research Network

Activity Timeline